210 related articles for article (PubMed ID: 20946455)
1. Fragrance mix II in the baseline series contributes significantly to detection of fragrance allergy.
Heisterberg MV; Andersen KE; Avnstorp C; Kristensen B; Kristensen O; Kaaber K; Laurberg G; Menné T; Nielsen NH; Sommerlund M; Thormann J; Veien NK; Vissing S; Johansen JD
Contact Dermatitis; 2010 Nov; 63(5):270-6. PubMed ID: 20946455
[TBL] [Abstract][Full Text] [Related]
2. Patch testing with fragrance mix II: results of the IVDK 2005-2008.
Krautheim A; Uter W; Frosch P; Schnuch A; Geier J
Contact Dermatitis; 2010 Nov; 63(5):262-9. PubMed ID: 20946454
[TBL] [Abstract][Full Text] [Related]
3. Results of patch testing with fragrance mix 1, fragrance mix 2, and their ingredients, and Myroxylon pereirae and colophonium, over a 21-year period.
Nardelli A; Carbonez A; Drieghe J; Goossens A
Contact Dermatitis; 2013 May; 68(5):307-13. PubMed ID: 23601065
[TBL] [Abstract][Full Text] [Related]
4. Recommendation to include fragrance mix 2 and hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral) in the European baseline patch test series.
Bruze M; Andersen KE; Goossens A; ;
Contact Dermatitis; 2008 Mar; 58(3):129-33. PubMed ID: 18279149
[TBL] [Abstract][Full Text] [Related]
5. Fragrance contact allergy: a 4-year retrospective study.
Cuesta L; Silvestre JF; Toledo F; Lucas A; Pérez-Crespo M; Ballester I
Contact Dermatitis; 2010 Aug; 63(2):77-84. PubMed ID: 20573166
[TBL] [Abstract][Full Text] [Related]
6. Patch testing with a new fragrance mix - reactivity to the individual constituents and chemical detection in relevant cosmetic products.
Frosch PJ; Rastogi SC; Pirker C; Brinkmeier T; Andersen KE; Bruze M; Svedman C; Goossens A; White IR; Uter W; Arnau EG; Lepoittevin JP; Johansen JD; Menne T
Contact Dermatitis; 2005 Apr; 52(4):216-25. PubMed ID: 15859994
[TBL] [Abstract][Full Text] [Related]
7. Contact allergy to the 26 specific fragrance ingredients to be declared on cosmetic products in accordance with the EU cosmetics directive.
Heisterberg MV; Menné T; Johansen JD
Contact Dermatitis; 2011 Nov; 65(5):266-75. PubMed ID: 21943251
[TBL] [Abstract][Full Text] [Related]
8. Trends of contact allergy to fragrance mix I and Myroxylon pereirae among Danish eczema patients tested between 1985 and 2007.
Thyssen JP; Carlsen BC; Menné T; Johansen JD
Contact Dermatitis; 2008 Oct; 59(4):238-44. PubMed ID: 18844700
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral) is still a frequent allergen.
Braendstrup P; Johansen JD;
Contact Dermatitis; 2008 Sep; 59(3):187-8. PubMed ID: 18759910
[No Abstract] [Full Text] [Related]
10. Multicentre patch testing with fragrance mix II and hydroxyisohexyl 3-cyclohexene carboxaldehyde by the Swedish Contact Dermatitis Research Group.
Isaksson M; Inerot A; Lidén C; Lindberg M; Matura M; Möller H; Stenberg B; Bruze M
Contact Dermatitis; 2014 Mar; 70(3):187-9. PubMed ID: 24588374
[No Abstract] [Full Text] [Related]
11. Patch testing with a new fragrance mix detects additional patients sensitive to perfumes and missed by the current fragrance mix.
Frosch PJ; Pirker C; Rastogi SC; Andersen KE; Bruze M; Svedman C; Goossens A; White IR; Uter W; Arnau EG; Lepoittevin JP; Menné T; Johansen JD
Contact Dermatitis; 2005 Apr; 52(4):207-15. PubMed ID: 15859993
[TBL] [Abstract][Full Text] [Related]
12. Patch test concentrations (doses in mg/cm2 ) for the 12 non-mix fragrance substances regulated by European legislation.
Bruze M; Svedman C; Andersen KE; Bruynzeel D; Goossens A; Johansen JD; Matura M; Orton D; Vigan M;
Contact Dermatitis; 2012 Mar; 66(3):131-6. PubMed ID: 22320667
[TBL] [Abstract][Full Text] [Related]
13. Results of patch testing to personal care product allergens in a standard series and a supplemental cosmetic series: an analysis of 945 patients from the Mayo Clinic Contact Dermatitis Group, 2000-2007.
Wetter DA; Yiannias JA; Prakash AV; Davis MD; Farmer SA; el-Azhary RA
J Am Acad Dermatol; 2010 Nov; 63(5):789-98. PubMed ID: 20643495
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral®) as allergen: experience from a contact dermatitis unit.
Carvalho R; Maio P; Amaro C; Santos R; Cardoso J
Cutan Ocul Toxicol; 2011 Sep; 30(3):249-50. PubMed ID: 21345163
[TBL] [Abstract][Full Text] [Related]
15. A clinical and patch test study of patients with positive patch test reactions to fragrance mix in China.
Lu X; Li LF; Wang W; Wang J
Contact Dermatitis; 2005 Apr; 52(4):188-91. PubMed ID: 15859990
[TBL] [Abstract][Full Text] [Related]
16. Patch-testing with fragrance mix II.
Pónyai G; Németh I; Temesvári E
Dermatitis; 2011 May; 22(3):169-70. PubMed ID: 21569749
[No Abstract] [Full Text] [Related]
17. Clinical relevance of positive patch test reactions to the 26 EU-labelled fragrances.
van Oosten EJ; Schuttelaar ML; Coenraads PJ
Contact Dermatitis; 2009 Oct; 61(4):217-23. PubMed ID: 19825093
[TBL] [Abstract][Full Text] [Related]
18. Patch testing with the European baseline series fragrance markers: a 2016 update.
Ung CY; White JML; White IR; Banerjee P; McFadden JP
Br J Dermatol; 2018 Mar; 178(3):776-780. PubMed ID: 28960261
[TBL] [Abstract][Full Text] [Related]
19. Frequency of and trends in fragrance allergy over a 15-year period.
Nardelli A; Carbonez A; Ottoy W; Drieghe J; Goossens A
Contact Dermatitis; 2008 Mar; 58(3):134-41. PubMed ID: 18279150
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyisohexyl 3-cyclohexene carboxaldehyde allergy: relationship between patch test and repeated open application test thresholds.
Fischer LA; Menné T; Avnstorp C; Kasting GB; Johansen JD
Br J Dermatol; 2009 Sep; 161(3):560-7. PubMed ID: 19486000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]